baber/WOPTO huggingface dataset:
Patent AU-2017200231-A1 (AU)
Title: Ball valve seal with dynamic C-seal and static C-seal
Inventor: DALLUGE PAUL R
IPC: F16K5/06
Filed: 2017-01-13
Abstract: A seal assembly is provided for a rotary ball valve having a top-mounted bonnet (14), thereby allowing the seal assembly to be installed and removed without removing the valve from the pipeline. In an embodiment, the seal assembly may include a seal ring (44) disposed within the valve interior and biased toward the ball element of the valve. A seal carrier (46) may be disposed between the seal ring and the valve body, and the seal carrier may be removably secured to the valve body by a plurality of bolts disposed in the valve interior. A primary leak path (50) may exist between the seal ring and the seal carrier and a secondary leak path (52) may exist between the seal carrier and the valve body. A first and second auxiliary seal (82,56) may prevent fluid flow through the primary and secondary leak path, respectively. Figure 2 38a 136 40a 0102 1 0 1 0 134 140 104 130 11 - 48 38b- 4 9 114 --- 128 56- 8 8 132 150 101 6 140 46 80 - 146 12 78-- -66 -44 148 5 152 8654/758 6 18 + 61 30 22-
Patent AU-2017201568-A1 (AU)
Title: Optical correction
Inventor: SHARMA ANANT
IPC: A61P27/02
Filed: 2017-03-07
Abstract: A medicament for topical administration to a human or animal eye comprises at least two pharmacologically active agents. One of the active agents is a parasympathetic agonist, such as pilocarpine, and the other active agent is either a sympathetic antagonist such as dapiprazole or thymoxamine, or a sympathetic agonist such as brimonidine or iopidine. The medicament is preferably in the form of a liquid composition, such as eye drops, or a gel or ointment and may comprise a slow-release composition. The medicament acts to improve visual acuity for a period of several hours, and may be beneficial in cases of presbyopia, myopia, hypermetropia, astigmatism and/or impaired night vision.
Patent AU-2017203249-A1 (AU)
Title: Apparatus and method of manufacturing pressure compensator type drip irrigation tubes with desired molecular orientation and tubes obtained thereby
Inventor: PATRICK DEFRANK MICHAEL
IPC: B29C48/10
Filed: 2017-05-15
Abstract: A method for manufacturing high speed pressure compensator - type drip irrigation tubes and the tubes obtained thereby having absolute radial orientation of molecular chains, the orientation imparting strength as well as flexibility to the tube material. the said method comprises extruding a tube using a plurality of extruders; blowing up the extruded tube by introducing a pressure inside the tube relatively higher than the pressure outside the tube; drawing the blown tube simultaneously to the blowing of tube; flattening the blown tube by heat welding the collapsed halves together and forming a tape immediately, subsequent to the process of blowing and drawing the tube; extrusion of a bonding polymer on one border of the tape; printing flow channels into the hot and viscous bonding polymer; and forming a tube by lengthwise folding the tape and heat welding the overlapping borders together using the bonding polymer. MAHUA ROYCH0wDHURy (Authorized agent for the applicant)
Patent AU-2017203706-A1 (AU)
Title: Methods and Compositions for Treating Disorders
Inventor: NG HOWARD
IPC: A61K31/522
Filed: 2017-06-01
Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
Patent AU-2017203725-A1 (AU)
Title: Thienopyrimidine inhibitors of atypical protein kinase C
Inventor: DORSEY BRUCE D
IPC: C07D495/14
Filed: 2017-06-02
Abstract: The present invention provides a compound of formula (1) or a salt thereof, 5 wherein R', R2 , R3,R4 ,R5 , R6 , A, G, M, Q and X are as defined herein. A compound of formula (1) and its salts have a PKC inhibitory activity, and may be used to treat proliferative disorders.
Patent AU-2017205019-A1 (AU)
Title: Glycosaminoglycan ester and application thereof
Inventor: HUANG YONG
IPC: A61P31/04
Filed: 2017-01-04
Abstract: A new biomaterial is disclosed. The biomaterial is prepared by mixing glycosaminoglycan with a phosphoric acid, phosphate ester, salt or derivative under the action of a catalyzing agent in a liquid reaction medium at a pH of 2.1 to 4.9, thus obtaining a material capable of enhancing immunological resistance in humans and animals, treating diseases in humans and animals caused by viruses or bacteria, strengthening stress resistance in animals, increasing appetite in animals, promoting animal growth, inhibiting tumor growth, lowering blood fat level, as well as preventing and treating viral diseases in plants.
Patent AU-2017208874-A1 (AU)
Title: Amine derivatives of lupanes with HIV maturation inhibitory activity
Inventor: JOHNS BRIAN ALVIN
IPC: A61P31/18
Filed: 2017-01-19
Abstract: The present invention relates to compounds characterized by having a structure according to the following Formula I: (I) or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.
Patent AU-2017216574-A1 (AU)
Title: Method and system for evaluating the resiliency of a distributed computing service by inducing latency
Inventor: TSEITLIN ARIEL
IPC: H04L12/26
Filed: 2017-08-18
Abstract: Techniques are disclosed for validating the resiliency of a networked application made available using a distributed computing infrastructure. In one embodiment, a latency monitoring application observes each active application component and at specified or 5 unspecified intervals, selects one and introduces latency or error messages in one or more messages emanating from the selected active application component. The latency monitoring application then measures the effect of the latency or error messages on other active application components that are dependent on the affected active application component. By observing the effects of the failed server on the rest of the network 10 application, a provider can ensure that each component can tolerate any unexpected latency or error conditions with the distributed computing infrastructure.
Patent AU-2017228670-A1 (AU)
Title: An electronic eyeglass system
Inventor: ABREU MARCIO MARC AURELIO MARTINS
IPC: G02C5/14
Filed: 2017-09-14
Abstract: Abstract Detachable wearable electronic eyeglasses and head mounted gear with a plurality of electronic functions and interchangeable electronic function, and a wearable computer with optimal weight distribution and stretchable arms.
Patent AU-2017235278-A1 (AU)
Title: Oligonucleotides for reduction of PD-L1 expression
Inventor: PEDERSEN LYKKE
IPC: C07H21/00
Filed: 2017-03-14
Abstract: The present invention relates to antisense oligonucleotides that are capable of reducing expression of PD-L1 in a target cell. The oligonucleotides hybridize to PD-L1 mRNA. The present invention further relates to conjugates of the oligonucleotide and pharmaceutical compositions and methods for treatment of viral liver infections such as HBV, HCV and HDV; a parasite infections such as malaria, toxoplasmosis, leishmaniasis and trypanosomiasis or liver cancer or metastases in the liver using the oligonucleotide.
Patent AU-2017248349-A1 (AU)
Title: Leveling system for lift device
Inventor: HAO JIHONG
IPC: B60G9/02
Filed: 2017-04-07
Abstract: A leveling assembly for a lift device (10) includes a carrier arm, an axle, a first actuator, and a second actuator. The carrier arm includes a base that defines a first interface configured to pivotally couple the carrier arm to a chassis of the lift device (10) to facilitate a pitch adjustment of the leveling assembly, a projection that defines a second interface, and a transition that extends between the base and the projection at an angle such that the projection is elevated relative to the base. The axle defines a third interface positioned to engage with the second interface to pivotally couple the axle to the carrier arm to facilitate a roll adjustment of the leveling assembly. The first actuator is pivotally coupled to the chassis and a first lateral end of the axle. The second actuator is pivotally coupled to the chassis and an opposing second lateral end of the axle.
Patent AU-2017250948-A1 (AU)
Title: Positive electrode for alkaline water electrolysis and method for producing positive electrode for alkaline water electrolysis
Inventor: KATO AKIHIRO
IPC: C25B11/06
Filed: 2017-04-05
Abstract: Provided are: a positive electrode for alkaline water electrolysis, which is obtained at low cost and is capable of achieving low overvoltage; and a method for producing a positive electrode for alkaline water electrolysis. A positive electrode for alkaline water electrolysis, which is characterized by forming, on the surface of a conductive base 1 that is formed from nickel or a nickel-based alloy, electrode catalyst layers 2, 3 that are formed from a first catalyst component comprising a nickel cobalt spinel oxide or a lanthanoid nickel cobalt perovskite oxide and a second catalyst component comprising at least one of iridium oxide and ruthenium oxide; and a method for producing this positive electrode for alkaline water electrolysis.
Patent AU-2017251040-A1 (AU)
Title: Microneedle array
Inventor: SHIMADA TOSHIO
IPC: A61K47/02
Filed: 2017-04-12
Abstract: The present invention addresses the problem of providing a microneedle array for which liposome aggregation can be suppressed when mixing a water-soluble polymer with liposomes and in which medicine can be localized at a tip of a needle portion during the production of the microneedle array. According to the present invention, the microneedle array includes a sheet portion, and a plurality of needle portions on an upper surface of the sheet portion, the needle portions including a water-soluble polymer, medicine, liposome, and salt. The liposome has a zeta potential of -10 mV or less, the zeta potential being the zeta potential of a liquid in which the liposome is diluted to 0.1 mg/mL with 10 mmol/L of an aqueous phosphoric acid solution having a pH of 7. The salt content of the portion of each needle portion that contains the liposome is 2.5 mmol/g or less.
Patent AU-2017254345-A1 (AU)
Title: Novel Crystalline salt forms of 3-(1,2,4-Triazolo(4,3-a)Pyridine-3-Ylethynyl)-4-Methyl-n-(4-((4-Methylpiperazin-1-yl)Methyl)-3-Trifluoromethylphenyl)Benzamide for medical application
Inventor: CHILOV GERMES GRIGORIEVICH
IPC: A61P35/00
Filed: 2017-04-18
Abstract: The invention relates to the organic chemistry, pharmacology and medicine, and concerns the prevention and treatment of human and animal diseases associated with the disruption of the activity of various kinases, in particular Abl kinase, for example diseases such as leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, acute lymphocytic leukemia, breast cancer, non-small cell lung cancer, gastrointestinal stromal tumors, ovarian cancer, lymphoma, using a new salt form of 3-(1,2,4-triazolo[4,3-a]pyridine-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl)benzamide. The salt of this compound with methanesulfonic acid, formula (I), or its hydrate, solvate, as well as polymorphic modifications that have the ability to inhibit the activity of kinases, in particular Abl kinases. The present invention also relates to pharmaceutical compositions comprising a therapeutically effective amount of a salt of the invention, to a method for preparing a crystalline salt of the invention, as well as to a method for treating oncological diseases in a subject.
Patent AU-2017268645-A1 (AU)
Title: Upper guide track and assembly for a retractable screen
Inventor: ROBERTS ANTHONY GERARD
IPC: E05D15/06
Filed: 2017-11-30
Abstract: An upper guide track assembly (10) for a horizontally opening retractable screen is described. The guide track assembly (10) comprises a U shaped guide channel (11), an elongate track attachment member (20) for attaching the guide track assembly to a support that has a wall section defining an inner side wall (12) of the guide channel and an elongate track outer member (40) connectable to the attachment member (20) that has a wall section defining the outer side wall (14) of the guide channel (11) and an elongate screen retaining member (80) within the guide channel (11). The elongate screen retaining member (80) comprises an elongate body (82) with a lower longitudinal channel (84) for receiving and retaining an upper edge of a retractable screen. The screen retaining member (80) has two opposed substantially resilient wings (86, 88) extending from either of the elongate body. Each wing is biased towards a position in which the distal end of each wing is away from the body. The wings are is moveable against the bias to a wing retracted position. When the screen retaining member is retained in the guide channel (11), each wing is held in the retracted position against the bias by contact with the side walls (12, 14) of the guide channel (11). This allows an upper edge of a retractable screen retained by the screen retaining member (80) to be biased in the vertical direction.
Patent AU-2017306164-A1 (AU)
Title: Spiro-lactam NMDA modulators and methods of using same
Inventor: KHAN M AMIN
IPC: A61P25/00
Filed: 2017-08-01
Abstract: Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Patent AU-2017314052-A1 (AU)
Title: Device for frictionally and/or interlockingly fastening a component to a vehicle frame
Inventor: HUNDERTPFUND FRANK
IPC: B60K15/067
Filed: 2017-08-08
Abstract: The invention relates to a device for frictionally and/or interlockingly fastening a component, preferably a tank, to a vehicle frame, comprising at least one upper fastening plate, which can be coupled to an upper region of the tank, and at least one lower fastening plate, which can be coupled to the tank below the at least one upper fastening plate, wherein the fastening plates are designed to transfer the weight of the tank largely or exclusively in particular to an upper flange sheet and/or a lower flange sheet of a longitudinal member of the vehicle frame.
Patent AU-2017333056-A1 (AU)
Title: Non-solvated crystal, preparation method and application thereof
Inventor: LU XIANPING
IPC: A61P11/06
Filed: 2017-09-27
Abstract: The invention relates to non-solvated crystals A, B and C of N-(2-aminophenyl)-6-(7-methoxyquinoline-4-oxy)-1-naphthamide and preparation methods thereof. The invention also relates to pharmaceutical compositions containing the crystals, and a use of the crystals in preparation of a medicament for the treatment of a disease associated with abnormal protein kinase activity or abnormal histone deacetylase activity.
Patent AU-2017338040-A1 (AU)
Title: Control of aperiodic signalling of SRS for wireless systems
Inventor: MUNIER FLORENT
IPC: H04W72/00
Filed: 2017-09-29
Abstract: 42A wireless device, network node and methods are provided. The network node includes processing circuitry configured to configure an aperiodic sounding reference signal, A-SRS, switching trigger, and transmit the configured A-SRS 5 switching trigger to a wireless device. The A-SRS switching trigger is one of: a downlink control information, DCI, of a predetermined DCI format and a DCI of another predetermined DCI format for group switching. In one embodiment, the predetermined DCI format is one of 2, 2A and 3, and the other predetermined DCI format for group switching is 1A. 10
Patent AU-2017368288-A1 (AU)
Title: Fermentation process
Inventor: DE HAAN ANDRE BANIER
IPC: C12P7/56
Filed: 2017-11-29
Abstract: The invention pertains to a process for manufacturing a fermentation product comprising - fermenting under fermentation conditions in an aqueous fermentation medium in a fermentation reactor a carbohydrate source with a microorganism capable of converting the carbohydrate into a fermentation product, wherein the fermentation product is a salt or a product with a boiling point above the boiling point of water, - during the fermentation process withdrawing part of the fermentation medium comprising biomass from the fermentation reactor in the form of a recycle stream, - providing the recycle stream comprising biomass to a pressure vessel wherein the pressure is selected such that the temperature of the recycle stream decreases with a value of 1- 8º C, as compared to the temperature of the fermentation medium in the fermentation reactor, by the evaporation of water - recycling the cooled recycle stream to the fermentation reactor. It has been found that the process according to the invention makes it possible to obtain a homogeneous temperature profile of the fermentation medium with limited occurrence of hot or cool spots within the reactor. This has been found to result in improved fermentation performance.
Patent AU-2017377216-A1 (AU)
Title: Electrode, redox flow battery, and method for producing electrode
Inventor: KAJIWARA KENTARO
IPC: H01M8/18
Filed: 2017-12-11
Abstract: The purpose of the present invention is to provide: an electrode which is used in a liquid permeation device that is reduced in the liquid permeation resistance, while having enhanced utilization efficiency of the surfaces of carbon fibers; and a redox flow battery which exhibits excellent charge and discharge performance by using this electrode that is used in a liquid permeation device. The present invention is an electrode which is used in a liquid permeation device, and which is obtained by laminating a plurality of carbon fiber nonwoven fabrics that have a relief structure in the surface, or that alternatively have through holes, while having a plurality of voids inside, said voids not opening in the thickness direction and being formed by recesses in the relief structure or by the through holes.
Patent AU-2017378783-A1 (AU)
Title: Cyclic dinucleotide sting agonists for cancer treatment
Inventor: CEMERSKI SASO
IPC: C07H21/00
Filed: 2017-12-15
Abstract: Therapies comprising administering at least one cyclic dinucleotide compound that activates the Stimulator of Interferon Genes (STING) pathway, and the use of such therapies in the treatment of cell-proliferation disorders such as cancer, are disclosed herein.
Patent AU-2017381393-A1 (AU)
Title: Metal-air fuel cell
Inventor: DANSIE MARK
IPC: H01M6/22
Filed: 2017-12-07
Abstract: The application relates to a metal-air fuel cell and uses thereof including use as a long-life, mechanically rechargeable, direct current power source for devices and products.
Patent AU-2017416198-A1 (AU)
Title: Jet flow anaerobic bioreactor for treating high-concentration organic wastewater
Inventor: WEI CHAOHAI
IPC: C02F101/30
Filed: 2017-11-30
Abstract: A jet anaerobic bioreactor for treating a high-concentration organic sewage, comprising a reactor main body zone (1), and a gas purification zone (2) and a separation sedimentation zone (3) provided on two sides thereof. The reactor main body zone (1) is connected to an outlet end of an ejector (5) via an injection pipe (4), the water inlet end of the ejector (5) is connected to the separation sedimentation zone (3) via a circulating water pipe (6), and the gas inlet end of the ejector (5) is connected to the gas purification zone (2) via a biogas pipe (7). A mixed liquid connection hole (8) in communication with the separation sedimentation zone (3) is provided in the middle part of the reactor main body zone (1), and a sludge return hole (9) in communication with the bottom of the reactor main body zone (1) is provided at the bottom of the separation sedimentation zone (3). The reactor realizes complete and uniform mixing of the sewage and sludge and fluidization in the reactor by means of a biogas anaerobic jet produced by the reactor itself, and is suitable for the treatment of high-concentration organic sewage having poor biochemical properties as the biogas is in a closed loop state and the fluidization effect is less affected by the biogas production.
Patent AU-2018201331-A1 (AU)
Title: Compositions and methods for regulating hair growth
Inventor: COTSARELIS GEORGE
IPC: A61Q7/00
Filed: 2018-02-23
Abstract: The invention relates to compositions and methods for regulating hair growth. Specifically, the invention relates to regulating hair growth by regulating the activity one of the prostaglandin D2 (PGD2) receptors, DP-2 (GPR44). Compositions and methods for regulating hair growth include inhibiting hair growth by administering a DP-2 agonist, or stimulating hair growth by administering a DP-2 antagonist.
Patent AU-2018201792-A1 (AU)
Title: Information transmission method, base station, and user equipment
Inventor: NAN FANG
IPC: H04L1/08
Filed: 2018-03-13
Abstract: This application provides an information transmission method, a base station, and user equipment. The method includes: determining a first frequency resource, where the first frequency resource is a frequency resource used to send first information in an enhanced manner; determining a second frequency resource, where the second frequency resource is a frequency resource used to send second information or send second information in an enhanced manner; and when there is an overlapping frequency resource between the first frequency resource and the second frequency resource, sending, in an available subframe for sending the first information in an enhanced manner, the first information in an enhanced manner by using the first frequency resource, where the available subframe is one or more subframes other than a subframe in a subframe set for sending the second information or sending the second information in an enhanced manner; or sending, in a subframe in a subframe set for sending the second information or sending the second information in an enhanced manner, the first information in an enhanced manner on a frequency resource other than the overlapping frequency resource in the first frequency resource. Determine a first frequency resource, where the first 101 frequency resource is a frequency resource used to send first information in an enhanced manner Determine a second frequency resource, where the second frequency resource is a frequency resource 102 used to send second information or send second information in an enhanced manner 103 \/104 When there is an overlapping frequency resource between the first When there is an overlapping frequency resource and the second frequency resource between the frequency resource, send, in an first frequency resource and the available subframe for sending the second frequency resource, first information in an enhanced send, in a subframe in a manner, the first information in an subframe set for sending the enhanced manner by using the first second information or sending frequency resource, where the the second information in an available subframe for sending the enhanced manner, the first first information in an enhanced information in an enhanced manner is one or more other manner on a frequency resource subframes than a subframe in a other than the overlapping subframe set for sending the second frequency resource in the first information or sending the second frequency resource information in an enhanced manner